Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Net Study
2008:74:1;80-80
doi: 10.4103/0378-6323.38431
PMID: 18193504

Clinical study of cutaneous drug eruptions in 200 patients

M Patel Raksha, YS Marfatia
 Department of Skin and V. D, Medical College, Vadodara, India

Correspondence Address:
M Patel Raksha
R-3, Doctor's Quarters, Jail Road, Vadodara - 390 001
India
How to cite this article:
Raksha M P, Marfatia Y S. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:80
Copyright: (C)2008 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

Two hundred patients (112 males and 88 females) with cutaneous drug eruption were studied. The aim was to recognize the offending drug, to evaluate mortality and morbidity, educate the patient and avoid self-administration and readministration of drugs. Fixed drug eruption was the commonest reaction, seen in 61 patients; other reactions being urticaria and angioedema, morbilliform rash in 37, pruritus in 25, Stevens Johnson Syndrome (SJS) in 6, purpura in 6, exfoliative dermatitis in 5, photosensitivity in 5, toxic epidermal necrolysis in 2, acneiform eruption in 3, erythema multiforme in 2. Maximum patients belonged to the age group 41-50, followed by 21-30 and 31-40 years. The youngest was 1 year old and the oldest was 80 years old. Period of development of lesion after intake of drug varied from 1 day to 45 days. Cotrimoxazole was the commonest drug, in 26 cases; followed by Ibuprofen in 20 cases.
Keywords: Adverse drug reaction, Cutaneous drug eruption
Table 5: Urticaria and angioedema
Table 5: Urticaria and angioedema
Table 4: Morbilliform rash
Table 4: Morbilliform rash
Table 3: Drugs causing fixed drug eruptions
Table 3: Drugs causing fixed drug eruptions
Table 2: Clinical pattern of drug eruption in the present study
Table 2: Clinical pattern of drug eruption in the present study
Table 1: Age and sex distribution of drug eruption in the present study
Table 1: Age and sex distribution of drug eruption in the present study
Figure 4: Sulfone syndrome
Figure 4: Sulfone syndrome
Figure 3: Exfoliative dermatitis due to NSAIDs
Figure 3: Exfoliative dermatitis due to NSAIDs
Figure 2: Exfoliative dermatitis due to NSAIDs
Figure 2: Exfoliative dermatitis due to NSAIDs
Figure 1: Fixed drug eruption due to cotrimoxazole
Figure 1: Fixed drug eruption due to cotrimoxazole

Introduction

Cutaneous drug eruptions have become very common in recent times. The incidence of cutaneous drug eruptions is about 2.2% and is higher amongst inpatients and females. [1] Fatal reactions to drugs occur even though benign reactions are more common. The incidence increases in proportion to the number of drugs prescribed.

The best history comes not from asking ′What do you take?′ but from asking ′What do you take for fever, cold, sinuses or headache?′

Cutaneous drug eruptions are the most common adverse reactions attributed to drugs. Any skin disorder can be imitated, induced or aggravated by drugs. The present study was carried out to know the age, sex incidence and clinical pattern of drug reactions, to recognize the offending drug (self-medication or prescribed), to evaluate mortality and morbidity associated with drugs, to educate the patients, to avoid self-administration of drugs and readministration of offending drugs. The diagnosis of cutaneous drug eruptions is based on detailed history and correlation between drug intake and the onset of rash. The history-taking for drug intake is an art, which includes direct, indirect, suggestive, evocative and repetitive questioning. It takes time, but answers are golden in case of cutaneous drug reactions and drug-induced dermatitis.

Methods

A prospective study comprising of 200 cases of drug reaction was carried out from July 1997 to June 2006. The diagnosis was based on detailed history and clinical examination.

Patients with cutaneous drug reactions attending Skin-V.D. Department, SSG Hospital, Vadodara, were studied. Precise history of drug ingestion, including allopathic, homeopathic, herbal remedies, and self-medication was taken. Careful history of symptoms, other existing skin and systemic diseases, atopy, and past history, family history of drug reaction or any other illness were taken. Thorough clinical examination was carried out. Skin, hair, nail and mucosa (eye, oral and genital) were examined.

The diagnosis of cutaneous drug reaction was based on history of drug ingestion, clinical findings and exclusion of other similar disorders. Diagnosis was confirmed by observing disappearance of signs and symptoms after discontinuation of drugs. Re-challenge was done as and when possible in less severe types of reactions.

Complete blood count, routine and microscopic examination of urine and stool were carried out in all patients. Specific or relevant investigations such as liver function test (LFT), renal function test (RFT), VDRL and ELISA for HIV were carried out in selected patients.

Results

Two hundred patients (112 males and 88 females) were studied. Maximum patients belonged to the age group of 41-50 years, followed by 21-30 and 31-40 years [Table - 1]. The youngest patient was 1 year old and the oldest was of 80 years old. Period of development of lesions after intake of drug varied from 1 day to 45 days.

Cotrimoxazole was the most implicated drug, in 26 cases; followed by Ibuprofen in 20 cases. The commonest pattern of cutaneous drug reaction observed was FDE (Fixed Drug Eruption) (30.5%), followed by urticaria in 18.5%, morbilliform rash in 18% and pruritus in 12.5% [Table - 2].

FDE [Table - 3] occurred most commonly due to cotrimoxazole (29.5%), followed by NSAIDs (nonsteroidal anti-inflammatory drugs) in 22.8%, urticaria in 18.5%, morbilliform rash in 18% [Table - 4] and pruritus in 12.5%. NSAIDs were also the main culprit in causing urticaria, angioedema [Table - 5] and morbilliform rash.

Twenty-five cases presented with pruritus, out of which two were because of antituberculous therapy [isoniazid (INH), rifampicin, pyrazinamide, ethambutol] and three were due to cotrimoxazole. Others were due to drugs like ampicillin, ibuprofen, APC (aspirin, paracetamol and codeine), hydroxyzine hydrochloride, vitamin A and chloroquine.

There were seven cases of SJS, out of which three (42.8%) were due to ibuprofen. Two cases of SJS were severe, but they were managed successfully with intensive care. In addition to this, there were two cases of TEN (Toxic epidermal necrolysis), out of which one case due to rifampicin was severe but responded well to treatment and one case of TEN because of unknown drug proved fatal.

Photosensitivity was seen in four cases, mainly due to ciprofloxacin and sparfloxacin. Five cases of exfoliative dermatitis (2.5%) occurring due to carbamazepine (two), ibuprofen and NSAIDs and dapsone were seen. There were four cases of purpura, the culprit drugs being aspirin, chloroquine, griseofulvin and an unknown drug. One case of angular cheilitis presented due to isotretinoin.

Other than cutaneous drug reactions, we had three cases of hemorrhagic cystitis and one case of aplastic anemia due to cyclophosphamide.

Re-challenge was done in 40 cases of mild cutaneous drug reaction, out of which positive results were found in 29 cases.

Patients were given a list of common drugs causing particular types of reactions and advised to avoid these drugs, chemically related drugs and OTC (over-the-counter) products.

They were instructed that even ayurvedic and other alternative medicines can cause adverse drug reactions. Even their family members were advised to avoid particular groups of drugs.

Discussion

The most common drugs causing reactions were NSAIDs, in 42 cases (21%); followed by sulpha in 28 cases (14%) in our study. Pudukadan et al. reported cotrimoxazole (22.25%), followed by dapsone (17.7%), as the commonest culprit. [2]

The commonest pattern was FDE (30.5%), followed by urticaria (18.5%) and morbilliform rash (18%). Similar to this, Pudukadan D et al, reported the commonest pattern to be FDE (31.1%), followed by maculopapular rash (12.2%). [2] Malhotra et al, reported morbilliform rash in 29.63%, SJS/TEN in 22.22% and urticaria in 9.26% cases as common patterns of reaction. [3] Jhaj et al. reported 50% cases of morbilliform rash, 21% cases of urticaria, 13.9% cases of SJS and 4.9% cases of TEN. [4]

Most of the patients had taken medicine for pain, fever and infection. Cotrimoxazole was the commonest cause of FDE in our study, similar to that found in the study by Singh et al. [5] NSAIDs and cotrimoxazole were also found to be the common cause of cutaneous drug reaction in the study by Shrivastav et al. [6]

Additives and preservatives are common causes of urticaria. The exact percentage of reactions to additives is not known but is considered to be important in fewer than 10% of patients with chronic urticaria. Most frequently implicated food additives are tartrazine, other azo-dyes including amaranth and sunset yellow. [7]

One case of sulfone syndrome (DDS Syndrome - exfoliative dermatitis, fever, generalized lymphadenopathy and raised LFT) [Figure - 4] was observed in our study, while dapsone (sulfone) syndrome was observed in 10 (1.6%) out of 604 patients over a period of 4 years in the study by Prasad PV. [8]

Quinolones were a common cause of morbilliform rash and photosensitivity in our study, which might be because of increased use of quinolones.

Ibuprofen was the commonest cause of erythema multiforme (EM) and (Stevens Johnson′s syndrome) SJS in our study, whereas one case of SJS was reported due to paracetamol. Halevi et al, reported TEN due to acetaminophen, [9] while carbamazepine was the commonest cause of TEN and SJS in the study by Devik et al. [10]

The incidence of acneiform eruptions induced by INH was 0.53% in the study by Sharma PP, [11] while we had two cases of acneiform eruptions due to INH.

One case of pruritus was probably induced by (1%) hydroxyzine hydrochloride.

Every drug must be regarded as potentially hazardous. For each patient, the risk must be weighed against the expected therapeutic benefit.

References
1.
Sehgal S, Balachandran C, Shenoi SD. Clinical study of cutaneous drug reaction in 80 patients. Indian J Dermatol Venereol Leprol 2003;69:6-7.
[Google Scholar]
2.
Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care centre in South India. Indian J Dermatol Venereol Leprol 2004;70:20-4.
[Google Scholar]
3.
Malhotra S, Chopra SC, Dogra A, Gupta C. Cutaneous adverse drug reactions- one year pharmacovigilance study in a tertiary care hospital. Indian J Pharmacol 2004;36:S41-2.
[Google Scholar]
4.
Jhaj R, Uppal R, Malhotra S, Bhargava VK. Cutaneous adverse reactions in in-patients in a tertiary care hospital. Indian J Dermatol Venereol Leprol 1999;65:14-7.
[Google Scholar]
5.
Singh KK, Shrinivas CR, Krupashankar DS, Naik RPC. Study of thirty three cases of fixed drug eruption, Indian J Dermatol Venereol Leprol 1990;56:123-4.
[Google Scholar]
6.
Shrivastava D, Kumar A, Singh SK. Adverse drug reaction monitoring in patients attending skin O.P.D at a teaching hospital. Indian J Pharmacol 2004;36:S42.
[Google Scholar]
7.
Pollock I, Young E, Stoneham M, Slater N, Wilkinson JD, Warner JO. Survey of colorings and preservatives in drugs. BMJ 1989;299:649-51.
[Google Scholar]
8.
Prasad PV. A study of Dapsone syndrome at a rural teaching hospital in south India. Indian J Dermatol Venereol Leprol 2001;67:69-71.
[Google Scholar]
9.
Halevi A, Ben-Amitai D, Garty BZ. Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000;34:32-4.
[Google Scholar]
10.
Devi K, George Sandhya, Criton S, Suja V. Carbamazepine-The commonest cause of toxic epidermal necrolysis and Steven Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol 2005;71:325-8.
[Google Scholar]
11.
Sharma RP, Kothari AK, Sharma NK. Acneform eruptions and Antitubercular drugs. Indian J Dermatol Venereol Leprol 1995;61:26-7.
[Google Scholar]

Fulltext Views
2,993

PDF downloads
2,170
Show Sections